Sign In
Buy XLV
$152.18
+2.12 (+1.41%)
At Close: Jun 23, 2026
Should You Be Overwhelmed by Solid Q4 Earnings? ETFs to Play
02:00pm, Thursday, 08'th Feb 2024
The Q4 of 2023 earnings season has emerged as a surprising success story. However, the cautionary note is that these gains come after a substantial reduction in earnings forecasts, and the outlook for
5 Sector ETFs to Play for Revenue Growth in Q4
09:01am, Thursday, 08'th Feb 2024
The fourth quarter earnings reporting cycle is ongoing. Though investors' top focus remains on bottom line during an earnings reason, top line probably tells you more about the inherent strength of a
Health care's underperformance last year sets it up well for 2024, says Mara Goldstein
07:34am, Thursday, 08'th Feb 2024
Mara Goldstein, Biotech Analyst at Mizuho, discusses health care's outperformance this week.
3 Sector ETFs & Stocks to Bet on Superb January Jobs Data
02:01pm, Wednesday, 07'th Feb 2024
The U.S. economy added 353,000 for the month, much better than the Dow Jones estimate for 185,000 (as quoted on CNBC).
Forget Rate Cuts, Buy Top-Ranked Sector ETFs
11:00am, Tuesday, 06'th Feb 2024
Powell expressed confidence in the economic growth and jobs market. Amid the strong economy, investors could be well served by ETFs from top-ranked sectors.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
07:21am, Tuesday, 23'rd Jan 2024
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Health Care Select Sector SPDR ETF (XLV), a passively managed exchange traded fund launched o
Healthcare In 2024: Navigating The Biopharma Bull Run
11:22pm, Wednesday, 17'th Jan 2024
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to
Charts turn bullish on health-care stocks as sector takes early lead in 2024
11:29am, Tuesday, 16'th Jan 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h
5 Closed-End Fund Buys In The Month Of December 2023 (Plus 1 Sell)
05:02am, Tuesday, 16'th Jan 2024
Equity and fixed-income markets had another strong month in December, driven by continuing retreating risk-free Treasury rates. We even saw an improvement in the breadth of the overall market, with br
UnitedHealth Beats on Q4 Earnings, Shares Slip: ETFs in Focus
12:02pm, Monday, 15'th Jan 2024
The largest U.S. health insurer UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2023 results but medical costs rose more than expected for the first time in two years.
Healthcare ETF (XLV) Hit a 52-Week High
08:16am, Wednesday, 10'th Jan 2024
For investors seeking momentum, Health Care Select Sector SPDR ETF XLV is probably on the radar. The fund just hit a 52-week high and is up 15.5% from its 52-week low price of $122.59/share.
Here are Wall Street's favorite stocks in the sector expected to grow profits the most in 2024
09:13am, Tuesday, 09'th Jan 2024
Each earnings reporting season, you can count on a flurry of articles with headlines saying companies “beat” consensus estimates for quarterly profits. But that “success” alone means nothing.
4 Sector ETFs & Stocks to Bet on December Jobs Data
03:02pm, Monday, 08'th Jan 2024
The U.S. economy added 216,000 jobs in December, higher than the 170, 000 expected by economists.
Are defensive sectors ready to outshine growth in 2024?
07:50am, Saturday, 06'th Jan 2024
The Health Care Select Sector SPDR Fund NYSEARCA: XLV, which has both growth and defensive characteristics, was the leader in the first week of the year. Top sector performers included Moderna Inc. NA
Healthcare ETFs Start 2024 on a Positive Note
01:32pm, Thursday, 04'th Jan 2024
After underperforming in 2023, the healthcare sector seems to be back on track at the start of the New Year. Healthcare generally outperforms during periods of low growth and high uncertainty.
